Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuing Anticoagulants and Antiplatelets in Cold Snare Polypectomy
2024-511265-11-01Phase 4Authorised
- Sponsor
- IIS Aragón
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel, dabigatran, rivaroxaban, apixaban, acenocoumarol and 1 more in thromboembolism, coronary arteriosclerosis, cerebrovascular disease and 1 more (2 arms), sponsored by IIS Aragón. Primary endpoint: Significant post-polypectomy hemorrhage. Planned start Jul 2024; status: authorised.
02
Drugs
clopidogreldabigatranrivaroxabanapixabanacenocoumarol
03
Conditions
thromboembolismcoronary arteriosclerosiscerebrovascular diseasevenous thromboembolism (VTE)
Beyond the preview
Go deeper on 2024-511265-11-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-511265-11-01.